Emmessar Biotech & Nutrition Ltd

Emmessar Biotech Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Emmessar Biotech & Nutrition Ltd

₹ 25.6 -4.93%
15 May - close price
ebnl.org BSE: 524768
About

Incorporated in 1992, Emmessar Biotech & Nutrition Ltd is in the business of Healthcare, Fine Chemicals and Renting of Immovable property[1]

Key Points

Business Overview:[1]
EBNL is a global healthcare company that manufactures and markets healthcare & nutritional products. It fuses various concepts & principles (both ancient & modern) from Biophysics, Biochemistry, Biotechnology and the Indian system of medicine AYUSH (Ayurveda + Yoga + Unani + Siddha + Homeopathy) to create products. This integration resulted in technology called VedaCeuticals which forms the foundation of all products of EBNL

Website BSE
  • Market Cap ₹ 12.8 Cr.
  • Current Price ₹ 25.6
  • High / Low ₹ 42.9 / 18.4
  • Stock P/E 29.2
  • Book Value ₹ 16.2
  • Dividend Yield 0.00 %
  • ROCE 7.33 %
  • ROE 5.56 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of -44.4% over past five years.
  • Company has a low return on equity of 6.71% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
0.32 0.07 0.08 0.33 0.08 0.08 0.34 0.10 0.10 0.09 0.09 0.09 0.09
0.48 0.35 0.30 0.54 0.47 0.36 0.42 0.38 0.43 0.36 0.46 0.43 0.46
Operating Profit -0.16 -0.28 -0.22 -0.21 -0.39 -0.28 -0.08 -0.28 -0.33 -0.27 -0.37 -0.34 -0.37
OPM % -50.00% -400.00% -275.00% -63.64% -487.50% -350.00% -23.53% -280.00% -330.00% -300.00% -411.11% -377.78% -411.11%
0.42 0.46 0.53 0.53 0.48 0.46 0.51 0.43 0.61 0.53 0.54 0.49 0.47
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.03 0.03 0.03
Profit before tax 0.24 0.16 0.29 0.30 0.07 0.16 0.41 0.13 0.26 0.24 0.14 0.12 0.07
Tax % 20.83% 68.75% 31.03% 56.67% -285.71% 43.75% 31.71% 84.62% 126.92% 25.00% 21.43% 8.33% 57.14%
0.20 0.05 0.20 0.13 0.27 0.09 0.28 0.02 -0.07 0.17 0.11 0.12 0.03
EPS in Rs 0.40 0.10 0.40 0.26 0.54 0.18 0.56 0.04 -0.14 0.34 0.22 0.24 0.06
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
2.19 1.98 2.61 1.27 0.63 3.40 6.99 0.36 1.02 0.56 0.61 0.37
2.34 2.66 2.38 1.67 1.27 3.81 6.15 1.26 1.71 1.64 1.56 1.73
Operating Profit -0.15 -0.68 0.23 -0.40 -0.64 -0.41 0.84 -0.90 -0.69 -1.08 -0.95 -1.36
OPM % -6.85% -34.34% 8.81% -31.50% -101.59% -12.06% 12.02% -250.00% -67.65% -192.86% -155.74% -367.57%
0.06 0.03 0.98 1.25 1.01 1.21 1.47 1.92 1.75 1.99 2.01 2.04
Interest 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.07 0.03 0.01 0.05 0.08 0.06 0.06 0.09 0.09 0.10 0.10 0.10
Profit before tax -0.16 -0.68 1.19 0.80 0.29 0.74 2.25 0.93 0.97 0.81 0.96 0.58
Tax % -25.00% -30.88% 0.00% -15.00% -82.76% -2.70% 36.00% 48.39% 47.42% 7.41% 66.67% 24.14%
-0.12 -0.47 1.19 0.91 0.53 0.75 1.45 0.48 0.50 0.75 0.32 0.44
EPS in Rs -0.24 -0.94 2.38 1.82 1.06 1.50 2.90 0.96 1.00 1.50 0.64 0.88
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: -15%
5 Years: -44%
3 Years: -29%
TTM: -39%
Compounded Profit Growth
10 Years: 14%
5 Years: -21%
3 Years: -4%
TTM: 38%
Stock Price CAGR
10 Years: 6%
5 Years: 3%
3 Years: 4%
1 Year: -26%
Return on Equity
10 Years: 15%
5 Years: 7%
3 Years: 7%
Last Year: 6%

Balance Sheet

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00
Reserves -3.62 -4.09 -2.91 -2.01 -1.49 -0.73 0.70 1.17 1.67 2.41 2.71 3.12
0.00 0.00 0.00 0.00 0.07 0.00 0.00 0.00 0.08 0.11 0.00 0.00
1.03 1.36 1.13 0.92 1.59 1.86 2.11 1.04 1.19 1.23 1.51 1.41
Total Liabilities 2.41 2.27 3.22 3.91 5.17 6.13 7.81 7.21 7.94 8.75 9.22 9.53
1.42 0.73 0.72 2.25 1.99 1.91 1.86 2.07 2.00 1.91 1.81 1.72
CWIP 0.00 0.00 0.80 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
0.98 1.53 1.69 1.65 3.17 4.21 5.94 5.13 5.93 6.83 7.40 7.80
Total Assets 2.41 2.27 3.22 3.91 5.17 6.13 7.81 7.21 7.94 8.75 9.22 9.53

Cash Flows

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
-0.01 0.75 0.74 0.39 1.03 0.47 2.27 0.38 0.64 0.22 0.27
0.00 -0.74 -0.69 -0.37 -1.06 0.01 -2.61 -0.55 -0.64 -0.23 -0.26
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01
Net Cash Flow -0.01 0.01 0.05 0.01 -0.03 0.48 -0.34 -0.17 0.00 0.00 0.02
Free Cash Flow -0.01 -0.06 -0.04 0.39 1.03 0.47 1.96 0.35 0.64 0.22 0.26
CFO/OP 7% 343% -198% -61% -251% 68% -284% -46% -57% -25% -11%

Ratios

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 6.67 66.36 5.59 8.62 23.17 3.22 141.51 10.14 3.58 13.04 11.97 19.73
Inventory Days 335.80 136.88 121.67 52.14 2,049.62 272.56 7.24 196.54 127.75 164.25 230.53 405.56
Days Payable 150.87 76.04 76.04 5.79 1,628.46 189.61 51.70 56.15 0.00 18.25 0.00 40.56
Cash Conversion Cycle 191.60 127.20 51.22 54.97 444.33 86.18 97.05 150.52 131.33 159.04 242.49 384.73
Working Capital Days 38.33 22.12 85.31 175.31 457.70 30.06 79.37 -60.83 114.51 91.25 35.90 98.65
ROCE % -10.81% -39.30% 80.00% 31.50% 17.66% 25.48% 45.14% 15.67% 15.02% 11.35% 12.61% 7.33%

Insights

In beta
Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Revenue from Domestic Sales
INR Lakhs

Log in to view insights

Please log in to see hidden values.

Login
Revenue from Export Sales
INR Lakhs
Lease and Rental Income
INR Lakhs
Total Number of Permanent Employees
Count
Product Portfolio Categories
Count

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

2 Recently
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
59.33% 59.53% 59.53% 59.53% 59.53% 59.53% 59.53% 59.53% 59.53% 59.53% 59.53% 59.53%
0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19%
40.46% 40.27% 40.28% 40.26% 40.27% 40.27% 40.28% 40.27% 40.28% 40.28% 40.27% 40.26%
No. of Shareholders 6,8746,8226,8447,1466,9006,9367,1867,1807,1737,3507,2447,172

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports